A triple-drug regimen combining two immunotherapy agents with radiation before surgery appears to activate immune defenses ...

Early results from preclinical studies and a clinical trial led by researchers at the UCLA Health Jonsson Comprehensive ...

Efti in combination with pembrolizumab and radiotherapy demonstrates significant efficacy in the neoadjuvant setting in patients with soft tissue sarcoma Over three-fold increase in tumour ...

Soft tissue sarcomas are rare solid tumors that are being increasingly classified and treated by subtype. Approximately 12,020 people will be diagnosed with a soft tissue sarcoma in the United States ...

Many MRI exams for soft tissue sarcomas fail to meet recommended guidelines, affecting grading accuracy and clinical outcomes. Only 2 out of 64 patients received a complete set of ...

The parents of a woman who died from a rare cancer say delays in her diagnosis and treatment may have affected how long she ...

Angiosarcoma is an aggressive malignancy derived from endothelial cells, characterised by its rapid progression, heterogeneity and distinct clinical challenges. As a subset of soft tissue sarcomas, ...

Novel biomarkers like GDF15 and OPN show promise in diagnosing and prognosticating uterine sarcoma, potentially enabling early identification and tailored therapy. Blood-based markers such as NLR and ...

University of Maryland School of Medicine researchers are investigating a new approach to treat high-risk soft-tissue sarcomas by combining two immunotherapy drugs with radiation therapy to stimulate ...

Iovance Biotherapeutics reported early pilot trial results for lifileucel in aggressive soft tissue sarcomas. The company plans to start a registrational trial and seek expedited FDA approval based on ...